- Home
- Publications
- Publication Search
- Publication Details
Title
Natural killer cells in hepatitis C virus infection
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 8, Issue 8, Pages 775-788
Publisher
Informa UK Limited
Online
2012-11-21
DOI
10.1586/eci.12.71
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Umbilical Cord Blood T Cells Express Multiple Natural Cytotoxicity Receptors after IL-15 Stimulation, but Only NKp30 Is Functional
- (2014) Q. Tang et al. JOURNAL OF IMMUNOLOGY
- Telaprevir
- (2012) Caroline M. Perry DRUGS
- Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: Impaired viral kinetics and therapeutic response
- (2012) Susanna Naggie et al. HEPATOLOGY
- Antiviral strategies in hepatitis C virus infection
- (2012) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
- (2012) Kerstin A. Stegmann et al. JOURNAL OF INFECTIOUS DISEASES
- Hepatitis C Virus Infection of Human T Lymphocytes Is Mediated by CD5
- (2012) M. A. Sarhan et al. JOURNAL OF VIROLOGY
- Yet another role for natural killer cells: Cytotoxicity in immune regulation and viral persistence
- (2012) C. A. Biron PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New opportunities in anti-hepatitis C virus drug discovery: Targeting NS4B
- (2011) Roopa Rai et al. ANTIVIRAL RESEARCH
- Characterization of killer immunoglobulin-like receptor genetics and comprehensive genotyping by pyrosequencing in rhesus macaques
- (2011) Anna J Moreland et al. BMC GENOMICS
- All-Cause, Liver-Related, and Non-Liver-Related Mortality Among HCV-Infected Individuals in the General US Population
- (2011) S. S. El-Kamary et al. CLINICAL INFECTIOUS DISEASES
- Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment
- (2011) Federica Bozzano et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Early Changes in Natural Killer Cell Function Indicate Virologic Response to Interferon Therapy for Hepatitis C
- (2011) Golo Ahlenstiel et al. GASTROENTEROLOGY
- IL28Bgenetic variation and treatment response in patients with hepatitis C virus genotype 3 infection
- (2011) Amir Moghaddam et al. HEPATOLOGY
- Human leukocyte antigen–B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen–C (-C1/-C2) subgrouping using pyrosequence analysis
- (2011) Elisabetta Ugolotti et al. HUMAN IMMUNOLOGY
- Role of Common-Gamma Chain Cytokines in NK Cell Development and Function: Perspectives for Immunotherapy
- (2011) Raffaella Meazza et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Involvement of Activating NK Cell Receptors and Their Modulation in Pathogen Immunity
- (2011) Francesco Marras et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution
- (2011) Andrea De Maria et al. Journal of Translational Medicine
- Cell-to-Cell Contact with Hepatitis C Virus-Infected Cells Reduces Functional Capacity of Natural Killer Cells
- (2011) J. C. Yoon et al. JOURNAL OF VIROLOGY
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
- (2011) Nicolas F Delahaye et al. NATURE MEDICINE
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structure of the Vibrio cholerae cytolysin heptamer reveals common features among disparate pore-forming toxins
- (2011) S. De et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity
- (2011) P. A. Lang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Infections and Organ Transplantation: New Challenges for Prevention and Treatment of Hepatitis C Virus
- (2011) P. Burra et al. TRANSPLANTATION PROCEEDINGS
- Mechanisms of non-response to antiviral treatment in chronic hepatitis C
- (2011) Stephane Chevaliez et al. Clinics and Research in Hepatology and Gastroenterology
- KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection
- (2011) Nafisa-Katrin Seich al Basatena et al. PLoS Pathogens
- Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
- (2010) N. K. Bjorkstrom et al. BLOOD
- CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
- (2010) S. Lopez-Verges et al. BLOOD
- Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus
- (2010) Barbara Amadei et al. GASTROENTEROLOGY
- Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes
- (2010) T. Durand et al. GUT
- Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro
- (2010) Lucy Golden-Mason et al. HEPATOLOGY
- Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus
- (2010) Niklas K. Björkström et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intrahepatic IL-10 Maintains NKG2A + Ly49 − Liver NK Cells in a Functionally Hyporesponsive State
- (2010) Matthew G. Lassen et al. JOURNAL OF IMMUNOLOGY
- Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses
- (2010) Silke Paust et al. NATURE IMMUNOLOGY
- The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFNα Production
- (2010) Irene Bonaccorsi et al. PLoS One
- Regulation of human NK-cell cytokine and chemokine production by target cell recognition
- (2009) C. Fauriat et al. BLOOD
- NK Cell Receptors and Their Interactions with MHC
- (2009) Roberto Biassoni et al. CURRENT PHARMACEUTICAL DESIGN
- Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa–Dependent Manner
- (2009) Golo Ahlenstiel et al. GASTROENTEROLOGY
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C
- (2009) Paula Bonorino et al. JOURNAL OF HEPATOLOGY
- Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection
- (2009) Stefania Crotta et al. JOURNAL OF HEPATOLOGY
- NKp44 Receptor Mediates Interaction of the Envelope Glycoproteins from the West Nile and Dengue Viruses with NK Cells
- (2009) O. Hershkovitz et al. JOURNAL OF IMMUNOLOGY
- Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus Infection
- (2009) J. R. Vidal-Castineira et al. JOURNAL OF VIROLOGY
- The history of the “natural history” of hepatitis C (1968-2009)
- (2009) Leonard B. Seeff LIVER INTERNATIONAL
- What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?
- (2009) Alfredo Alberti LIVER INTERNATIONAL
- Adaptive immune features of natural killer cells
- (2009) Joseph C. Sun et al. NATURE
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- (2009) David L. Thomas et al. NATURE
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- NK Cell Function in HIV-1 Infection
- (2008) Andrea De Maria et al. CURRENT HIV RESEARCH
- Tumor cell recognition by the NK cell activating receptor NKG2D
- (2008) Yenan T. Bryceson et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Hepatitis C Virus Replicates in the Same Immune Cell Subsets in Chronic Hepatitis C and Occult Infection
- (2008) Tram N.Q. Pham et al. GASTROENTEROLOGY
- Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
- (2008) Anna S. Lok et al. GASTROENTEROLOGY
- Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure
- (2008) L Golden-Mason et al. GUT
- Natural killer cell function is intact after direct exposure to infectious hepatitis C virions
- (2008) Joo Chun Yoon et al. HEPATOLOGY
- Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production
- (2008) K. Saito et al. JOURNAL OF VIROLOGY
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
- Interferon signaling and treatment outcome in chronic hepatitis C
- (2008) M. Sarasin-Filipowicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started